GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Bio-Sincerity Pharma-Tech Co Ltd (SZSE:301096) » Definitions » Total Equity

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Total Equity : ¥2,741 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Bio-Sincerity Pharma-Tech Co Total Equity?

Hangzhou Bio-Sincerity Pharma-Tech Co's total equity for the quarter that ended in Mar. 2024 was ¥2,741 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Hangzhou Bio-Sincerity Pharma-Tech Co Total Equity Historical Data

The historical data trend for Hangzhou Bio-Sincerity Pharma-Tech Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Bio-Sincerity Pharma-Tech Co Total Equity Chart

Hangzhou Bio-Sincerity Pharma-Tech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial 278.74 339.55 2,317.77 2,482.26 2,684.14

Hangzhou Bio-Sincerity Pharma-Tech Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,533.11 2,544.69 2,600.28 2,684.14 2,741.39

Hangzhou Bio-Sincerity Pharma-Tech Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Hangzhou Bio-Sincerity Pharma-Tech Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=3669.106-984.969
=2,684

Hangzhou Bio-Sincerity Pharma-Tech Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=3834.691-1093.302
=2,741

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Bio-Sincerity Pharma-Tech Co Total Equity Related Terms

Thank you for viewing the detailed overview of Hangzhou Bio-Sincerity Pharma-Tech Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Business Description

Traded in Other Exchanges
N/A
Address
611 Dongguan Road, 2nd Floor, Building 8, Jinsheng Technology Park, Binjiang District, Hangzhou, CHN
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd is a pharmaceutical technology research and development company. The company's business covers drug discovery, pharmaceutical research, clinical research, and registration application.

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Headlines

No Headlines